left

What is the

co-innovation lab?

100px

It’s a first-of-its-kind collaboration that will combine advanced AI technology with some of the brightest minds in tech and science to solve the world’s toughest health challenges. Planned for San Francisco, the initiative will create continuous learning systems where world-class AI and scientific talent can build off each other, generating large-scale data to accelerate medicine discovery and improve the odds of success. The initiative will be supported by up to $1 billion in combined investment over five years from Lilly and NVIDIA and work is expected to begin March 31.

20px

one

left

How can collaborations like this help us advance medicine to help more people faster?

48px

Collaboration is key to quickly advancing scientific discovery—no single health care company can transform the industry alone. Collaborating with companies outside health care, like NVIDIA—the world leader in AI computing—provides a new, better way of working. By harnessing technology and combining it with scientific expertise, we have the potential to design better medicines at scale faster with greater confidence.

20px

one

Is this a new collaboration with NVIDIA?

48px

The investment builds on our October 2025 announcement of our supercomputer being built with another NVIDIA platform. The most powerful in the pharmaceutical industry, the supercomputer could expand our ability to discover, develop and distribute new medicines faster.

20px